NCT05300399 (MIND-the-SKIN) is a NA clinical trial of mHealth app in Skin Diseases, sponsored by Tulane University.

Who is sponsoring NCT05300399?

NCT05300399 is sponsored by Tulane University.

What drugs are being tested in NCT05300399?

Interventions in NCT05300399: mHealth app.

What condition does NCT05300399 study?

NCT05300399 studies Skin Diseases.

Is NCT05300399 still recruiting?

NCT05300399 is currently status unknown. Last updated 27 September 2022.

Last reviewed 2022-09-27 · How we verify

NCT05300399: MIND-the-SKIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digital Toolkit for Skin Diseases in LMICs

Status unknown NA Last updated 27 September 2022

What this trial tests

NA trial testing mHealth app in Skin Diseases in 1,364 participants. Status unknown.

Timeline

14 February 2022

Primary endpoint
31 May 2023

31 May 2023

Quick facts

Lead sponsor	Tulane University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	1,364
Start date	14 February 2022
Primary completion	31 May 2023
Estimated completion	31 May 2023
Sites	1 location across Côte d’Ivoire

Drugs / interventions tested

mHealth app

Conditions studied

Skin Diseases — all drugs for Skin Diseases →

Sponsor

Tulane University

Who can join

Eligibility, any sex, with Skin Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the early detection and effective management of skin diseases using the mHealth app in Cote d'Ivoire, a mixed-methods pilot trial will be conducted in Cote d'Ivoire. The pilot trial will consist of 3 phases: phase 1, development and improvement of the mHealth app; phase 2, pilot trial to evaluate the usability of the mHealth app for local healthcare providers in Cote d'Ivoire; and phase 3, pilot trial to evaluate the effectiveness of case detection and management of skin diseases with the mHealth app in Cote d'Ivoire. The pilot study will be implemented as a 2-arm trial with local healthcare providers and patients with skin diseases over a 3-month follow-up period.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Early Detection and Case Management of Skin Diseases With an mHealth App (eSkinHealth): Protocol for a Mixed Methods Pilot Study in Côte d'Ivoire.
Yotsu RR, Itoh S, Yao KA, Kouadio K, et al · · 2022 · cited 11× · PMID 35922062 · DOI 10.2196/39867
An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study.
Yotsu RR, Almamy D, Vagamon B, Ugai K, et al · · 2023 · cited 10× · PMID 37632977 · DOI 10.2196/46295

Verify or expand the search:

Other trials of mHealth app

Trials testing the same drug.

NCT06292260 — Digital Toolkit for Skin Diseases in LMICs: Part 2 · NA · recruiting
NCT04239911 — Leveraging Home Health Aides to Improve Outcomes in Heart Failure · NA · completed
NCT06361056 — Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials · NA · completed
NCT04858295 — Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease · NA · completed
NCT05724966 — Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma · completed

Other recruiting trials for Skin Diseases

Currently open trials in the same condition.

NCT07412691 — A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases · Phase 1 · recruiting
NCT07091604 — An Observational Study to Assess Objective Skin Pigmentation Variation. · recruiting
NCT07158879 — Skin Reactions Related to Thoracic Implantable Chamber Dressings · recruiting
NCT06850311 — Herbal Ointment in Treating Atopic Dermatitis Topically · Phase 2, PHASE3 · recruiting
NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting

Other Tulane University trials

Trials by the same sponsor.

NCT04007276 — The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients · Phase 4 · not yet recruiting
NCT07062406 — Enhancing Diabetes Care by Treating Insomnia · NA · not yet recruiting
NCT06810739 — The Women's Screening and Self-Testing Program (PROMETA) Study · NA · not yet recruiting
NCT05197998 — Promoting ColorBRAVE Conversations in Families · NA · suspended
NCT06261840 — Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05300399 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tulane University
Last refreshed: 27 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05300399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing